Fuling Technology
001356
KLT
831689
Pansoft
300996
4
Wuxi Xinhongye Wire & Cable
301310
5
Hand Enterprise Solutions
300170
US Stock MarketDetailed Quotes
REGN Regeneron Pharmaceuticals
- 680.030
- -7.770-1.13%
Close Jan 22 16:00 ET
- 680.030
- 0.0000.00%
Post 20:01 ET
74.73BMarket Cap16.82P/E (TTM)
699.880High677.680Low945.30KVolume689.770Open687.800Pre Close646.97MTurnover0.89%Turnover Ratio19.56P/E (Static)109.89MShares1211.20052wk High2.55P/B71.99BFloat Cap666.24952wk Low--Dividend TTM105.86MShs Float1211.200Historical High--Div YieldTTM3.23%Amplitude4.610Historical Low684.414Avg Price1Lot Size
Regeneron Pharmaceuticals News
Regeneron Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Third Quarter 2024 Financial and Operating Results
Regeneron Pharmaceuticals | 10-Q: Q2 2024 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Second Quarter 2024 Financial and Operating Results
Regeneron Pharmaceuticals | 10-Q: Q1 2024 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports First Quarter 2024 Financial and Operating Results
Regeneron Pharmaceuticals | 10-K: FY2023 Annual Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Regeneron Pharmaceuticals | 10-Q: Q3 2023 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Third Quarter 2023 Financial and Operating Results
Regeneron Pharmaceuticals | 10-Q: Q2 2023 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Second Quarter 2023 Financial and Operating Results
Regeneron Pharmaceuticals | 10-Q: Q1 2023 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports First Quarter 2023 Financial and Operating Results
Regeneron Pharmaceuticals | 10-K: FY2022 Annual Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
Regeneron Pharmaceuticals | 10-Q: Q3 2022 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Third Quarter 2022 Financial and Operating Results
Regeneron Pharmaceuticals | 10-Q: Q2 2022 Earnings Report
Regeneron Pharmaceuticals | 8-K: Regeneron Reports Second Quarter 2022 Financial and Operating Results
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace